全文获取类型
收费全文 | 6779篇 |
免费 | 420篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 263篇 |
妇产科学 | 135篇 |
基础医学 | 753篇 |
口腔科学 | 106篇 |
临床医学 | 1457篇 |
内科学 | 1152篇 |
皮肤病学 | 62篇 |
神经病学 | 526篇 |
特种医学 | 119篇 |
外科学 | 561篇 |
综合类 | 76篇 |
一般理论 | 9篇 |
预防医学 | 872篇 |
眼科学 | 83篇 |
药学 | 348篇 |
中国医学 | 1篇 |
肿瘤学 | 644篇 |
出版年
2024年 | 5篇 |
2023年 | 36篇 |
2022年 | 61篇 |
2021年 | 119篇 |
2020年 | 77篇 |
2019年 | 91篇 |
2018年 | 142篇 |
2017年 | 107篇 |
2016年 | 122篇 |
2015年 | 138篇 |
2014年 | 228篇 |
2013年 | 333篇 |
2012年 | 482篇 |
2011年 | 571篇 |
2010年 | 300篇 |
2009年 | 263篇 |
2008年 | 487篇 |
2007年 | 565篇 |
2006年 | 522篇 |
2005年 | 534篇 |
2004年 | 495篇 |
2003年 | 453篇 |
2002年 | 462篇 |
2001年 | 44篇 |
2000年 | 26篇 |
1999年 | 62篇 |
1998年 | 57篇 |
1997年 | 55篇 |
1996年 | 49篇 |
1995年 | 41篇 |
1994年 | 44篇 |
1993年 | 29篇 |
1992年 | 28篇 |
1991年 | 24篇 |
1990年 | 15篇 |
1989年 | 11篇 |
1988年 | 11篇 |
1987年 | 11篇 |
1986年 | 8篇 |
1985年 | 10篇 |
1984年 | 21篇 |
1983年 | 11篇 |
1982年 | 18篇 |
1981年 | 11篇 |
1980年 | 19篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1976年 | 2篇 |
1975年 | 3篇 |
1971年 | 1篇 |
排序方式: 共有7212条查询结果,搜索用时 31 毫秒
101.
High quality mental healthcare after a suicide attempt is a key strategy for preventing subsequent suicide attempts and deaths, yet little is known about how people navigate the healthcare system following a suicide attempt. This paper focuses on the stories told by 20 people who had attempted suicide. Five themes emerged: fitting into the healthcare system; need for advocacy; consistent care; lucky to find help; and, small kindnesses. Positive and empathetic healthcare experiences, as well as connected services, assisted the recovery of people who have attempted suicide. 相似文献
102.
103.
104.
Glenn?J.?Wagner Kathy?Goggin Robert?H.?Remien Marc?I.?Rosen Jane?Simoni David?R.?Bangsberg Honghu?Liu MACH Investigators 《Annals of behavioral medicine》2011,42(3):352-360
Background
Depression consistently predicts nonadherence to human immunodeficiency virus antiretroviral therapy, but which aspects of depression are most influential are unknown. Such knowledge could inform assessments of adherence readiness and the type of depression treatment to utilize. 相似文献105.
106.
Margaret F. Keil† Deborah P. Merke†‡§ Roma Gandhi Edythe A. Wiggs¶ Kathy Obunse§ Constantine A. Stratakis†‡ 《Clinical endocrinology》2009,71(3):326-333
Objective Cushing syndrome (CS) in children is associated with symptoms that may impair health related quality of life (HRQL). There are no prospective reports of HRQL in children with CS.
Methods Prospective study of 40 children (mean age 13 ± 3·2 years) with CS evaluated prior to and 1-year post-treatment. The Child Health Questionnaire (CHQ) was used to assess HRQL; Wechsler Intelligence Scale for Children (WASI) was used to assess cognitive function, and patient-reported symptoms were assessed with a CS symptom checklist.
Results Active CS was associated with low physical and psychosocial summary scores compared to US population data ( P < 0·001). Despite improvement from pre- to 1-year postcure, residual impairment remained in physical summary and function, and role-physical, global health and emotional impact (parent) scores. Incomplete recovery of adrenal function at 1-year post-treatment was associated with impaired scores. WASI IQ scores declined and a correlation was noted between age at first evaluation and IQ score changes. Most self-reported CS symptoms showed improvement, but forgetfulness, unclear thinking and decreased attention span did not improve after cure of CS.
Conclusion CS in children and adolescents is associated with impaired HRQL, with residual impairment 1 year after cure. Our results also suggest that younger children are more likely to experience negative changes in cognitive function. HRQL is an important outcome measure in children and adolescents with CS and identification of factors that contribute to HRQL may help to diminish the physical and psychological burden of disease in this population of patients. 相似文献
Methods Prospective study of 40 children (mean age 13 ± 3·2 years) with CS evaluated prior to and 1-year post-treatment. The Child Health Questionnaire (CHQ) was used to assess HRQL; Wechsler Intelligence Scale for Children (WASI) was used to assess cognitive function, and patient-reported symptoms were assessed with a CS symptom checklist.
Results Active CS was associated with low physical and psychosocial summary scores compared to US population data ( P < 0·001). Despite improvement from pre- to 1-year postcure, residual impairment remained in physical summary and function, and role-physical, global health and emotional impact (parent) scores. Incomplete recovery of adrenal function at 1-year post-treatment was associated with impaired scores. WASI IQ scores declined and a correlation was noted between age at first evaluation and IQ score changes. Most self-reported CS symptoms showed improvement, but forgetfulness, unclear thinking and decreased attention span did not improve after cure of CS.
Conclusion CS in children and adolescents is associated with impaired HRQL, with residual impairment 1 year after cure. Our results also suggest that younger children are more likely to experience negative changes in cognitive function. HRQL is an important outcome measure in children and adolescents with CS and identification of factors that contribute to HRQL may help to diminish the physical and psychological burden of disease in this population of patients. 相似文献
107.
Wiemels JL Xiao Z Buffler PA Maia AT Ma X Dicks BM Smith MT Zhang L Feusner J Wiencke J Pritchard-Jones K Kempski H Greaves M 《Blood》2002,99(10):3801-3805
Recent reports have established the prenatal origin of leukemia translocations and resultant fusion genes in some patients, including MLL-AF4 translocations in infants and TEL-AML1 translocations in children. We now report evidence for the prenatal origin of a translocation in childhood acute myeloid leukemia (AML). The t(8;21) AML1-ETO translocations were sequenced at the genomic level in 10 diagnostic leukemia samples from children with available neonatal Guthrie blood spots. Clonotypic genomic AML1-ETO sequences were detected in the Guthrie spots for 5 individuals, providing unambiguous evidence of prenatal origin in these cases. Two of these patients were older than 10 years of age at diagnosis, indicative of a protracted postnatal latency. Three of the patients were assessed for the persistence of genomic fusion sequences in complete clinical remission samples and were found to be positive. These data indicate that t(8;21) in childhood AML can arise in utero, possibly as an initiating event in childhood AML, and may establish a long-lived or stable parental clone that requires additional secondary genetic alterations to cause leukemia. 相似文献
108.
BACKGROUND: Prenatal ethanol exposure can retard fetal growth and delay skeletal development. Ethanol also impairs maternal calcium (Ca) homeostasis and this impairment could mediate some of ethanol's effects on the fetal skeleton. Our previous studies suggest that the duration of maternal ethanol consumption may be an important factor for determining the severity of ethanol's effects on Ca homeostasis and fetal skeletal development. The purpose of this study was, therefore, to determine the effect of the duration of maternal ethanol consumption on fetal growth and skeletal development and to investigate the possibility that ethanol's effects may be related to perturbations in fetal/maternal Ca homeostasis. METHODS: Rats were fed ethanol (36% ethanol-derived calories) in liquid diets for 3 weeks (days 1-21 of gestation) or 6 weeks (for 3 weeks before and throughout gestation). Fetuses were collected on day 21 of gestation, and body weight and length were measured. Fetuses were stained to determine the degree of skeletal ossification, and fetal blood was analyzed for ethanol, Ca (total and ionic Ca), albumin, parathyroid hormone (PTH), and osteocalcin. RESULTS: Maternal ethanol consumption decreased fetal growth and delayed fetal skeletal development. Although there was a trend for fetal body length and serum osteocalcin levels to be more severely affected with an increased duration of maternal ethanol consumption, duration had no effect on fetal body weight or skeletal ossification. Fetal Ca homeostasis was also affected by ethanol exposure, with fetal hypocalcemia apparent after 6 weeks of maternal ethanol intake. A significant inverse relationship was found between fetal blood Ca levels and blood alcohol concentration (BAC), suggesting that the severity of the fetal hypocalcemia may have been related to differences in fetal BAC, rather than duration of maternal ethanol intake. Fetal serum PTH levels did not differ significantly among treatment groups indicating that the fetal hypocalcemia was not caused by a decrease in PTH levels. CONCLUSIONS: Prenatal ethanol exposure impaired Ca homeostasis and skeletal development in the fetal rat. The severity of ethanol's effects was only marginally dependent on the duration of maternal ethanol consumption per se and seemed to be more related to the relative exposure of the fetus to ethanol (fetal BAC). The relationship between the ethanol-induced fetal hypocalcemia and skeletal effects remains to be determined. 相似文献
109.
Miller K Myers TJ Robertson K Shah N Delgado RM Gregoric ID 《Congestive heart failure (Greenwich, Conn.)》2004,10(5):226-229
Research suggests that ventricular assist devices improve quality of life for congestive heart failure patients awaiting heart transplantation. Axial flow ventricular assist devices like the Jarvik 2000 (Jarvik Heart, Inc., New York, NY) represent the newest type of ventricular assist device technology, but their effects on quality of life are not well understood. Therefore, the authors administered the Minnesota Living with Heart Failure Questionnaire to patients who had the Jarvik 2000 implanted as a bridge to heart transplantation. Patients completed the Minnesota Living with Heart Failure Questionnaire immediately before device implantation, 1 month after implantation, immediately before heart transplantation, and 1 month after transplantation. One month after implantation of the device, the nine patients who completed the study showed significant improvements in physical (p<0.008), emotional (p<0.02), and overall (p<0.008) quality of life. These improvements were maintained until the device was explanted. The authors conclude that implantation of the Jarvik 2000 ventricular assist device can substantially improve quality of life for patients awaiting heart transplantation. 相似文献
110.